CSL's revenue has fluctuated over the last three years, with a decline in 2023 due to market instability. Read why I rate CSL ...

The company has been awarded a big contract relating to pandemic preparation. The post Why are CSL shares charging higher today? appeared first on The Motley Fool Australia.

Under the multi-year contract CSL will deliver its MF59 adjuvant, an ingredient that can be used to manufacture vaccines against the H5 avian influenza virus. "This decision will further support the U ...

Biomedical Advanced Research and Development Authority (BARDA) and CSL Seqirus will expand their reserves of MF59® adjuvant to the equivalent of 40 million doses as part of the National Pre-Pandemic ...

CSL Vifor today announced that Japan's Ministry of Health and Labor Welfare (MHLW) has granted its partner, Zeria Pharmaceutical Co., Ltd. (Zeria), marketing authorization approval for Veltassa® for ...

The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...

Oppenheimer analyst Bryan Blair maintained a Buy rating on Carlisle Companies (CSL – Research Report) today and set a price target of ...

Citi analyst Mathieu Chevrier maintained a Buy rating on CSL (CMXHF – Research Report) today and set a price target of A$345.00. The ...

The race between Donald Trump and Kamala Harris is close, and market strategists are studying which stocks will do best. Here ...

Her microphone may have been muted when it wasn't her turn to speak, but Vice President Kamala Harris' facial expressions spoke volumes during her debate against former ...

Kaiser Permanente has sold a 21-story office tower and an adjoining five-story parking garage in downtown Oakland for a ...

Approval underscores CSL and Arcturus Therapeutics' commitment to delivering disruptive technologies to combat COVID-19 and other respiratory viral diseases to protect public health KOSTAIVE®, ...